Introduction
============

Impaired immunity in individuals with human immunodeficiency virus (HIV) infection affects the defense mechanisms against pathogens and alters the regulation of autoimmunity \[[@B1]\]. This may lead to the emergence of autoimmune disorders or modification of pre-existing conditions. Several conditions may remit, such as systemic lupus erythematosus (SLE), while others, such as psoriasis, intensify. The development of liver disease during highly active anti-retroviral treatment (HAART) in patients with HIV infection without evidence of co-infection with hepatitis viruses poses a diagnostic dilemma. This may be due to treatment side effects or to the emergence of autoimmune disorders during immune restoration.

Autoimmune hepatitis (AIH) is rare in patients with HIV infection. Additionally, hepatic involvement is unusual in other common autoimmune disorders. We present the case of a patient with AIH and SLE emerging *de novo*during HAART and review all previously reported cases of AIH in patients with HIV infection who are undergoing HAART.

Case presentation
=================

A 42-year-old African-American woman who had been diagnosed with HIV infection in 1989 acquired by heterosexual contact had a fluctuating CD4 count and a viral load secondary to non-adherence. In March 2009, she was extensively counseled on adherence to treatment and was started on a new regimen that included emtricitabine/tenofovir and etravirine. She became more compliant with treatment, and her clinical parameters improved. Before March 2009, her CD4 had been 157 cells/mm^3^and her viral load had been 120,000 copies/mL. One month after treatment adjustment, her CD4 went up to 232 cells/mm^3^and her viral load was undetectable. There was no personal or family history of autoimmune disease.

Six months after treatment adjustment she started to experience gradual right upper quadrant pain associated with intermittent night sweats. Her pain increased in intensity and became intractable. A computed tomographic scan of her abdomen was unremarkable. She was seen in the office with fever and tachycardia and was hospitalized because of possible sepsis and acute abdomen.

Her physical examination revealed that she was febrile (body temperature 102.1°F), tachycardic (130 beats/min) and hypoxic (O^2^saturation 84% on room air). Her chest examination revealed fine bibasilar crackles. Her abdominal examination demonstrated diffuse abdominal tenderness with rebound that was most prominent in the right upper quadrant.

A hepatobiliary iminodiacetic acid scan showed patent biliary ducts with a normal gallbladder ejection fraction. Computed tomography of the chest showed pericardial effusion that was confirmed by a transthoracic echocardiogram.

On day 3 of her hospitalization, she underwent a pericardial window, a pericardial biopsy and a laparoscopy with liver biopsy. The laparoscopy revealed a grossly abnormal liver (Figure [1](#F1){ref-type="fig"}). The liver biopsy demonstrated a dense portal lymphoplasmacytic infiltrate with multifocal zones of hepatocellular centrilobular necrosis consistent with AIH (Figure [2](#F2){ref-type="fig"}). Histological staining for fungi and mycobacterium were negative.

![**Laparoscopic image of the liver showing diffuse whitish-gray plaque without nodularity or cirrhosis**.](1752-1947-5-233-1){#F1}

![**Liver biopsy (hematoxylin and eosin stain) showing dense portal lymphoplasmacytic infiltrate and centrilobular hepatocellular necrosis caused by an acute chronic inflammatory infiltrate suggestive of autoimmune hepatitis**.](1752-1947-5-233-2){#F2}

Pertinent laboratory findings in this patient included alanine aminotransferase 1526 U/L, aspartate aminotransferase 777 U/L, international normalized ratio, 1.53; albumin level, 2.7 g/dL; anti-nuclear antibody (ANA) titer, 1:1280; negative anti-smooth muscle antibody; negative anti-cardiolipin and anti-ribosomal antibodies; anti-double-stranded DNA (anti-dsDNA) titer, 1:160; and immunoglobulin G level, 4600 mg/dL. Her antibodies to hepatitis viruses A, B and C and hepatitis B surface antigen were negative.

Given her clinical picture, her positive laboratory test for ANA and anti-dsDNA and the histopathology of her liver biopsy, a diagnosis of SLE with AIH was made. Her calculated AIH score was 19 (\> 15 is considered a definite diagnosis according to the International Autoimmune Hepatitis Group criteria).

The patient was initiated on high-dose steroid therapy (40 mg every 12 hours). By the next day, her abdominal pain had improved, and she was discharged from the hospital on a tapering dose of steroids.

One year after her hospitalization the patient remained in remission, with normal liver function and suppressed HIV viral load. Her steroid therapy was tapered off and stopped completely two months after being discharged from the hospital.

Discussion
==========

Our review of the literature revealed 12 cases of autoimmune hepatitis in patients with HIV infection \[[@B2]-[@B8]\]. Three had co-infections with hepatitis C virus and were receiving interferon therapy \[[@B6]-[@B8]\] and six more had AIH before starting HAART and one pediatric patient\'s data were missing. Only three patients developed AIH after starting HAART, similar to our patient. The clinical characteristics of the reviewed cases and our case are shown in Table [1](#T1){ref-type="table"}. All patients who received HAART prior to AIH had a significant rise in CD4 count and undetectable HIV RNA before AIH was diagnosed. Two patients had other concomitant autoimmune diseases, one with Grave\'s disease and the other with diffuse infiltrative lymphocytic syndrome. This review illustrates that AIH in patients with HIV infection on HAART is rare. It has been encountered in women who had significant elevations in CD4 count, suggesting the emergence of AIH during immune restoration. It presented insidiously with non-specific manifestations. The diagnosis is usually based on AIH score, the absence of other conditions and characteristic histopathological findings.

###### 

Characteristics of 11 reported patients with concomitant HIV and AIH^a^

  Case reports                   Patient age (years)/gender   Onset     CD4^b^/CD4^c^   VL^b^/VL^c^          AIH score   Outcome     Other AI diseases   ART
  ------------------------------ ---------------------------- --------- --------------- -------------------- ----------- ----------- ------------------- -----
  German *et al.*\[[@B2]\]       38^d^/man                    Chronic   216/384         81,000/\< 50         Probable    Excellent   Vetilligo           Yes
  Coriat and Podevin \[[@B7]\]   48/woman                     Acute     250             Undetectable         Probable    Died        None                Yes
  Puius *et al.*\[[@B3]\]        29/man                       Chronic   259/174         7122/27,732          Probable    Excellent   None                Yes
                                 45^d^/woman                  Chronic   253/297         8687/\< 50           Probable    Excellent   DILS                Yes
                                 65/woman                     Acute     200/922         Undetectable/\< 75   Definite    Excellent   None                Yes
  O\'Leary *et al.*\[[@B4]\]     44^d^/woman                  Chronic   269/526         4927/\< 50           Definite    Excellent   Grave\'s disease    Yes
  Wan *et al.*\[[@B5]\]          56/man                       Chronic   331/NA          232,734/NA           Probable    Died        None                
                                 54/man                       Chronic   357/213         5104/NA              Probable    Probable    Cirrhosis           Yes
                                 55/woman                     Chronic   174/NA          \< 50/NA             Probable    Probable    Poor                Yes
                                 49/woman                     Acute     286/NA          69,318/NA            Definite    Definite    Died                Yes
  Our patient                    42^d^/woman                  Acute     157/232         120,000/\< 50        Definite    Excellent   SLE                 Yes

^a^Two patients are not included because of lack of complete clinical data. HIV = human immunodeficiency virus; AIH = autoimmune hepatitis; AI, autoimmune; ART = antiretroviral treatment; VL = viral load; DILS = diffuse infiltrative lymphocytic syndrome; SLE = systemic lupus erythematosus; ^b^prior to initiating highly active antiretroviral treatment (HAART); ^c^after initiating HAART; ^d^patients with significant viral suppression on HAART who developed AIH.

In patients who develop liver function abnormalities while receiving HAART, it is important to exclude drug-induced liver disease. In our patient, the pathognomonic findings on the liver biopsy and the fact that she had been taking these medications long before she developed symptoms indicate that a drug reaction was not likely.

The prognosis associated with AIH in patients with HIV infection appears to be variable based on a review of 11 out of the 12 reported cases (one reported case\'s data were missing) of AIH in patients with HIV infection. Two patients died while receiving interferon therapy for hepatitis C virus that triggered fulminant AIH, and one died as a result of severe *Pneumocystis jiroveci*pneumonia while receiving high-dose steroids for the treatment of AIH.

Our patient had evidence of SLE in addition to AIH. Whether AIH is a manifestation of SLE or is unrelated is unclear. Liver involvement associated with AIH is relatively rare, ranging from 1.2% to 2% in patients with SLE who do not have HIV infection \[[@B9]\]. To date, it has not been reported simultaneously with SLE in patients with HIV infection.

The precise mechanism causing the emergence or unmasking of autoimmune conditions in patients who are HIV-positive who commence anti-retroviral therapy is complex and involves multiple cytokines and lymphocyte subsets \[[@B10]-[@B14]\]. Th17 cells have recently been implicated in association with chronic autoimmunity phenomena and especially in patients with HIV infection and primates with simian immunodeficiency virus \[[@B10]\]. An additional subset of CD4^+^regulatory T cells (Treg) has been described. It constitutively expresses CD25 and the transcription factor FoxP3 and has regulatory functions \[[@B1]\]. Although the levels of Treg in patients who are HIV-positive with autoimmune manifestations have not been reported, it seems plausible to propose that preferential depletion of Treg in some individuals could account for the increased autoimmune phenomena in some patients with acquired immunodeficiency syndrome \[[@B15]-[@B18]\].

Conclusion
==========

The present case report and review of the literature describes a rare complication of immune restoration in patients with HIV infection in the era of HAART. Recognizing AIH in the context of immune reconstitution and initiating appropriate therapy can be lifesaving. Treatment of these patients appears to be similar to that of patients without HIV infection.
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